Clinical Trial Update: Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated TCD Flow Velocity [Phase 2]

View source ↗

Summary

Phase 2 trial assessing whether hydroxyurea can prevent stroke in children with sickle cell disease and elevated transcranial Doppler flow velocity. The study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease
• Stroke

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Duke University | Conditions: Stroke | Phase 2 | Status: COMPLETED